Carpenter Technology Corp
CRS
$427.84
+8.59%
Carpenter Technology Corporation is a leading manufacturer of specialty metals and engineered products, serving critical end markets such as aerospace and defense, medical, energy, and industrial machinery. The company operates as a key supplier of high-performance alloys and advanced materials, positioning itself as an essential partner in supply chains that demand precision, reliability, and technical expertise. The current investor narrative is heavily focused on the company's strong leverage to the ongoing recovery and growth in the commercial aerospace sector, alongside robust demand from defense programs, which is driving significant revenue growth and margin expansion as evidenced by recent quarterly results.…
CRS
Carpenter Technology Corp
$427.84
Investment Opinion: Should I buy CRS Today?
Rating: Hold. The core thesis is that CRS is a high-quality company in a strong cyclical upswing, but its massive 109% rally and premium valuation have largely captured the near-term opportunity, presenting balanced risk/reward.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The forward P/E of 32.3x is a premium to industrials, limiting near-term upside. 2) Revenue growth remains positive at 7.55% YoY, but QoQ trends show potential plateauing. 3) Profitability expansion is the strongest story, with net income multiplying over 16x since Q3 2024. 4) The PEG ratio of 0.37 suggests growth is not fully priced, providing a long-term cushion. However, the stock trades at 93% of its 52-week high, indicating limited immediate technical runway.
Risks & Conditions: The two biggest risks are a cyclical downturn in aerospace and a valuation de-rating. This Hold would upgrade to a Buy if the forward P/E compresses below 25x on a market pullback without a deterioration in the earnings outlook, or if quarterly revenue re-accelerates above 10% YoY. It would downgrade to Sell if gross margins contract sequentially below 28% or if the stock breaks below key technical support at $361. The current verdict is that the stock is fairly valued to slightly overvalued relative to its peer group, but not egregiously so given its superior growth trajectory.
Sign up to view all
CRS 12-Month Price Forecast
The assessment is neutral based on a clash between stellar fundamental improvement and stretched valuation/technical levels. The earnings recovery story is compelling and real, evidenced by a net income margin expanding to 14.5%. However, the market has aggressively priced this in, with the stock trading near all-time highs at a significant sector premium. The key to an upgrade to bullish would be evidence that the current margin and earnings level is a new sustainable baseline, not a cyclical peak. Conversely, a downgrade to bearish would be triggered by a breakdown below $361, signaling the momentum has decisively reversed. The limited analyst coverage adds an element of uncertainty to the fair value calculation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carpenter Technology Corp's 12-month outlook, with a consensus price target around $556.19 and implied upside of +30.0% versus the current price.
Average Target
$556.19
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$342 - $556
Analyst target range
Analyst coverage for CRS is limited, with only two analysts providing estimates, indicating this is a smaller-cap name with less institutional scrutiny, which can contribute to higher volatility. The available data shows consensus revenue and EPS estimates for the coming period, but a specific consensus price target, recommendation distribution (Buy/Hold/Sell), and implied upside/downside are not available in the provided dataset. The lack of a broad analyst target range means there is less visible consensus on fair value, increasing the importance of independent fundamental and technical analysis for investors; the recent institutional ratings from firms like JP Morgan (Overweight), BTIG (Buy), and Keybanc (upgrade to Overweight) suggest a bullish bias among the limited coverage universe.
Bulls vs Bears: CRS Investment Factors
The bull case for CRS, anchored in a dramatic profitability recovery and dominant positioning in the resurgent aerospace cycle, currently holds stronger evidence. The surge in net income from $6.3M to $105.3M over seven quarters and robust free cash flow generation are concrete, high-impact positives. However, the bear case presents a formidable counter-argument centered on valuation risk, with a P/E of 36.9x far exceeding industrial peers. The single most important tension in the investment debate is whether CRS's explosive earnings growth can sustain long enough to justify its premium valuation, or if the stock is simply a late-cycle play priced for perfection. The resolution of this tension—specifically, the durability of margin expansion and top-line growth into 2026—will determine the stock's next major move.
Bullish
- Explosive Profitability Recovery: Net income surged to $105.3M in Q2 FY2026 from just $6.3M in Q3 FY2024, a 1,572% increase. Gross margin expanded to 29.99% from 21.46% a year ago, demonstrating powerful operating leverage from the aerospace recovery.
- Strong Aerospace & Defense Leverage: The Aerospace & Defense segment generated $472M in Q2 FY2026, representing 65% of total revenue and serving as the primary growth engine. This positions CRS to benefit directly from the multi-year commercial aerospace upcycle and sustained defense spending.
- Robust Balance Sheet & Cash Flow: The company boasts a strong current ratio of 3.65 and a low debt-to-equity ratio of 0.39, providing financial flexibility. Trailing twelve-month free cash flow of $316.7M supports internal growth and potential shareholder returns.
- Superior Technical Momentum: The stock has gained 108.97% over the past year and is trading at 93% of its 52-week high of $421.12, indicating powerful and sustained bullish momentum. It has significantly outperformed the S&P 500 by 86.77 percentage points over the same period.
Bearish
- Premium Valuation vs. Industrials: CRS trades at a trailing P/E of 36.9x and a forward P/E of 32.3x, a significant premium to typical Industrials sector multiples in the low 20s. This leaves the stock vulnerable to valuation compression if growth expectations falter.
- High Revenue Concentration Risk: Approximately 65% of revenue is derived from the Aerospace & Defense segment. This heavy reliance makes the company's fortunes highly sensitive to any cyclical downturn or project delays in this single end-market.
- Limited Analyst Coverage & Visibility: Only two analysts provide estimates for CRS, indicating lower institutional scrutiny and potentially higher volatility due to less consensus on fair value. The lack of a broad consensus price target increases uncertainty for investors.
- Technically Overextended: Trading at 93% of its 52-week high after a 109% rally, the stock is susceptible to a sharp technical correction. The recent 1-month decline of 2.39% and a beta of 1.24 confirm its above-market volatility and potential for pullbacks.
CRS Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 108.97% gain over the past year. As of the latest close of $391.51, the price is trading near the top of its 52-week range, approximately 93% of the way from its low of $138.61 to its high of $421.12, indicating strong momentum but also potential overextension relative to its recent trading band. Recent momentum shows some near-term consolidation, with a 1-month decline of 2.39%, which contrasts with the strong 3-month gain of 15.72%; this divergence suggests a healthy pullback within a longer-term uptrend, possibly allowing the stock to work off overbought conditions before its next leg higher. Key technical support is anchored at the 52-week low of $138.61, though more immediate support lies near the recent March low around $361, while resistance is clearly defined at the 52-week high of $421.12; a decisive breakout above $421 would signal a continuation of the bull trend, whereas a breakdown below $361 could indicate a deeper correction. The stock's beta of 1.24 indicates it is approximately 24% more volatile than the broader market, which is important for risk-aware investors to consider when sizing positions.
Beta
1.24
1.24x market volatility
Max Drawdown
-25.6%
Largest decline past year
52-Week Range
$147-$429
Price range past year
Annual Return
+182.8%
Cumulative gain past year
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | +8.1% | -0.3% |
| 3m | +33.2% | -2.0% |
| 6m | +77.5% | +3.5% |
| 1y | +182.8% | +36.2% |
| ytd | +26.5% | -0.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRS Fundamental Analysis
Revenue growth is robust and accelerating, with Q2 FY2026 revenue of $728 million representing a 7.55% year-over-year increase, building on a multi-quarter trend of sequential improvement from the $676.9 million reported in Q2 FY2025. The Aerospace and Defense segment is the primary growth driver, contributing $472 million in the latest period, significantly outpacing other segments like Energy ($50.8M) and Medical ($70.7M). Profitability has surged dramatically, with net income reaching $105.3 million in Q2 FY2026, compared to just $6.3 million in Q3 FY2024, while gross margin expanded to 29.99% in the latest quarter from 21.46% a year ago, reflecting improved pricing, product mix, and operational efficiency. The company's balance sheet is healthy, with a strong current ratio of 3.65 and a conservative debt-to-equity ratio of 0.39, indicating ample liquidity and low financial leverage. Free cash flow generation is solid, with trailing twelve-month FCF of $316.7 million, providing internal funding for growth initiatives and shareholder returns, as evidenced by a return on equity of 19.93%.
Quarterly Revenue
$728000000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$316700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRS Overvalued?
Given the company's substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 36.9x, while the forward PE is 32.3x; the lower forward multiple suggests the market anticipates continued earnings growth, with expectations embedded in the consensus EPS estimate of $15.40 for the coming period. Compared to the broader Industrials sector, CRS's trailing PE of 36.9x trades at a significant premium to typical industry averages, which often range in the low 20s; this premium is likely justified by the company's superior growth profile, margin expansion trajectory, and its niche leadership in high-value specialty metals. Historically, the stock's own trailing PE has ranged from deeply depressed levels during its downturn (e.g., 142x in Q3 2024 when earnings were minimal) to its current elevated level; trading near the top of its multi-year valuation band indicates the market is pricing in a very optimistic outlook for sustained cyclical recovery and peak profitability.
PE
36.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -66x~142x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CRS's primary financial risk is its premium valuation, not its balance sheet. The trailing P/E of 36.9x implies high expectations for sustained earnings growth; any deceleration could trigger a severe multiple contraction. While the balance sheet is strong (D/E of 0.39), operational risk is concentrated in the Aerospace & Defense segment, which generated 65% of Q2 revenue. A slowdown in commercial aerospace build rates or defense budget shifts would directly and significantly impact revenue and the high-margin profile, which saw gross margin expand to 29.99%.
Market & Competitive Risks: The stock faces significant market risk from its valuation premium relative to the Industrials sector. Trading at a P/E nearly double the sector norm, it is vulnerable to sector-wide de-rating or a rotation out of cyclical growth stocks. Its beta of 1.24 confirms it is 24% more volatile than the market, amplifying downside during broader sell-offs. Competitive risks include potential pricing pressure or market share loss within the niche specialty metals industry, though its technical expertise provides some moat.
Worst-Case Scenario: The worst-case scenario involves a double-whammy of an aerospace cycle slowdown coinciding with a broader market correction. This could lead to missed earnings expectations, multiple compression from 36.9x towards the sector average (~20x), and a technical breakdown. The realistic downside could see the stock re-test its 52-week low of $138.61, representing a potential loss of approximately -65% from the current price of ~$391. A more immediate bear-case target aligns with the recent technical support low near $361, suggesting a -8% downside risk in a moderate correction.
FAQ
The key risks are: 1) Valuation & Cyclical Risk: The high P/E of 36.9x makes the stock vulnerable to a sharp de-rating if the aerospace cycle shows signs of peaking. 2) Customer Concentration Risk: Approximately 65% of revenue comes from the Aerospace & Defense segment, creating dependency on one cyclical end-market. 3) Market Risk: With a beta of 1.24, the stock is 24% more volatile than the market, amplifying losses in a downturn. 4) Limited Visibility Risk: Sparse analyst coverage (only 2 analysts) can lead to higher price volatility and less consensus on fair value.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $360 and $420, as it digests its massive gains and growth normalizes. The Bull Case (30% probability) targets $421 to $480, requiring an acceleration of the aerospace cycle and further earnings beats. The Bear Case (20% probability) warns of a drop to $300-$360 on a growth scare or multiple compression. The base case is most likely, assuming the current robust demand environment persists but does not significantly accelerate from here. The key assumption is that quarterly earnings meet the consensus estimate of ~$15.40.
CRS is fairly valued to slightly overvalued based on traditional sector metrics, but its growth profile justifies a premium. Its trailing P/E of 36.9x and forward P/E of 32.3x are well above typical Industrials sector multiples, indicating the market is paying a premium. However, the PEG ratio of 0.37 suggests this premium is reasonable relative to its growth rate. The valuation implies the market expects the recent surge in profitability—net income margin of 14.5%—to be sustained, not just a temporary cyclical peak. Compared to its own history, it trades at an elevated multiple, reflecting peak-cycle optimism.
CRS is a good buy for investors who believe the aerospace upcycle has further room to run and are comfortable paying a premium for growth. The stock offers exposure to a dramatic earnings recovery, with net income up over 16-fold since mid-2024. However, with a 109% gain already in the past year and a P/E of 36.9x, much of the near-term opportunity appears priced in. The key risk is a -65% drawdown to the 52-week low if the cycle turns. It is a better buy on a significant pullback (towards $360) for long-term holders, rather than at current highs for short-term traders.
CRS is more suitable for a medium- to long-term investment horizon (2+ years) to fully capture the potential duration of the aerospace cycle and allow its earnings growth to justify the valuation. Its high beta of 1.24 and position near 52-week highs make it prone to sharp short-term swings, which traders could exploit but which are risky for buy-and-hold investors. The company pays a minimal dividend (0.29% yield), so it is not an income stock. Given its cyclical nature, investors should be prepared for volatility and have a horizon that extends through potential economic soft patches.